-
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis
Strijbis, E. M., Coerver, E., Mostert, J., van Kempen, Z. L. E., Killestein, J., Comtois, J., Repovic, P., Bowen, J. D., Cutter, G. & Koch, M., 1 Oct 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 10, p. 792-799 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-up
Coerver, E., Janssens, S., Ahmed, A., Wessels, M., van Kempen, Z., Jasperse, B., Barkhof, F., Koch, M., Mostert, J., Uitdehaag, B., Killestein, J. & Strijbis, E., Aug 2023, In: European journal of neurology. 30, 8, p. 2385-2392 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis
Coerver, E. M. E., Bourass, A., Wessels, M. H. J., van Kempen, Z. L. E., Jasperse, M. M. S., Tonino, B. A. R., Barkhof, F., Mostert, J., Uitdehaag, B. M. J., Killestein, J. & Strijbis, E. M. M., Jun 2023, In: Multiple Sclerosis and Related Disorders. 74, 104706.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
